The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome

Molecular Biology of the Cell

Volumn 22, Issue 24, 2011, Pages 4776-4786

  Mese, Gulistan ^a,c   Sellitto, Caterina ^a   Li, Leping ^a   Wang, Hong Zhan ^a   Valiunas, Virginijus ^a   Richard, Gabriele ^b   Brink, Peter R ^a   White, Thomas W ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b GENEDX   (United States)

^c IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26; DOXYCYCLINE; ENHANCED GREEN FLUORESCENT PROTEIN;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL HYPERPLASIA; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; EPIDERMIS; FEMALE; GENE MUTATION; HAIR LOSS; HEARING IMPAIRMENT; HISTOPATHOLOGY; HYPERKERATOSIS; HYPERPLASIA; ICHTHYOSIS; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; KERATITIS; KERATODERMA; LETHAL MUTANT; MEMBRANE CHANNEL; MITOSIS; MOUSE; NONHUMAN; PAPILLOMATOSIS; PATCH CLAMP; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKINFOLD; SYNDROME KID;

AMINO ACID SUBSTITUTION; ANIMALS; CONNEXINS; DEAFNESS; DISEASE MODELS, ANIMAL; EPIDERMIS; HELA CELLS; HUMANS; ICHTHYOSIS; KERATINOCYTES; KERATITIS; MICE; MICE, TRANSGENIC; MUTATION, MISSENSE;

EID: 84055176143     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-09-0778     Document Type: Article

References (75)

1. Abdollahi A, Hallaji Z, Esmaili N, Valikhani M, Barzegari M, Akhyani M, Toosi S, Miresmaili A (2007). KID syndrome. Dermatol Online J 13, 11.
2. Bakirtzis G et al. (2003). Targeted epidermal expression of mutant connexin 26(D66H) mimics true Vohwinkel syndrome and provides a model for the pathogenesis of dominant connexin disorders. Hum Mol Genet 12, 1737-1744. (Pubitemid 36896665)
3. Beltramello M, Piazza V, Bukauskas FF, Pozzan T, Mammano F (2005). Impaired permeability to Ins(1,4,5)P3 in a mutant connexin underlies recessive hereditary deafness. Nat Cell Biol 7, 63-69. (Pubitemid 40123384)
4. Benavides F, Oberyszyn TM, VanBuskirk AM, Reeve VE, Kusewitt DF (2009). The hairless mouse in skin research. J Dermatol Sci 53, 10-18.
5. Bennett MV, Contreras JE, Bukauskas FF, Saez JC (2003). New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci 26, 610-617. (Pubitemid 37338369)
6. Bikle DD, Oda Y, Xie Z (2004). Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation. J Steroid Biochem Mol Biol 89-90, 355-360. (Pubitemid 38844310)
7. Blanpain C, Fuchs E (2006). Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22, 339-373.
8. Blanpain C, Fuchs E (2009). Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10, 207-217.
9. Braun-Falco M (2009). Hereditary palmoplantar keratodermas. J Dtsch Dermatol Ges 7, 971-984.
10. Brown CW et al. (2003). A novel GJB2 (connexin 26) mutation, F142L, in a patient with unusual mucocutaneous findings and deafness. J Invest Dermatol 121, 1221-1223. (Pubitemid 37430998)
11. Bruzzone R, Veronesi V, Gomes D, Bicego M, Duval N, Marlin S, Petit C, D'Andrea P, White TW (2003). Loss-of-function and residual channel activity of connexin26 mutations associated with non-syndromic deafness. FEBS Lett 533, 79-88. (Pubitemid 36206386)
12. Bruzzone R, White TW, Paul DL (1996). Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238, 1-27. (Pubitemid 26164180)
13. Caputo R, Peluchetti D (1977). The junctions of normal human epidermis. A freeze-fracture study. J Ultrastruct Res 61, 44-61. (Pubitemid 8204367)
14. Di WL, Rugg EL, Leigh IM, Kelsell DP (2001). Multiple epidermal connexins are expressed in different keratinocyte subpopulations including connexin 31. J Invest Dermatol 117, 958-964. (Pubitemid 33001217)
15. Evans WH, De Vuyst E, Leybaert L (2006). The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem J 397, 1-14. (Pubitemid 44032830)
16. Fairley JA (1991). Calcium metabolism and the pathogenesis of dermatologic disease. Semin Dermatol 10, 225-231.
17. Gabriel HD, Jung D, Butzler C, Temme A, Traub O, Winterhager E, Willecke K (1998). Transplacental uptake of glucose is decreased in embryonic lethal connexin26-deficient mice. J Cell Biol 140, 1453-1461. (Pubitemid 28152993)
18. Gerido DA, DeRosa AM, Richard G, White TW (2007). Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness. Am J Physiol Cell Physiol 293, C337-C345. (Pubitemid 47105012)
19. Goliger JA, Paul DL (1994). Expression of gap junction proteins Cx26, Cx31.1, Cx37, and Cx43 in developing and mature rat epidermis. Dev Dyn 200, 1-13. (Pubitemid 24178283)
20. Goodenough DA (1974). Bulk isolation of mouse hepatocyte gap junctionsCharacterization of the principal protein, connexin. J Cell Biol 61, 557-563.
21. Goodenough DA, Paul DL (2003). Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 4, 285-294. (Pubitemid 36383955)
22. Griffith AJ et al. (2006). Cochleosaccular dysplasia associated with a connexin 26 mutation in keratitis-ichthyosis-deafness syndrome. Laryngoscope 116, 1404-1408. (Pubitemid 44181455)
23. Harris AL (2001). Emerging issues of connexin channels: biophysics fills the gap. Q Rev Biophys 34, 325-472.
24. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH (1980). Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19, 245-254. (Pubitemid 10154229)
25. Janecke AR, Hennies HC, Gunther B, Gansl G, Smolle J, Messmer EM, Utermann G, Rittinger O (2005). GJB2 mutations in keratitis-ichthyosis-deafness syndrome including its fatal form. Am J Med Genet A 133, 128-131. (Pubitemid 40279777)
26. Jonard L et al. (2008). A familial case of keratitis-ichthyosis-deafness (KID) syndrome with the GJB2 mutation G45E. Eur J Med Genet 51, 35-43. (Pubitemid 351175661)
27. Kanno Y, Loewenstein WR (1964). Low-resistance coupling between gland cells. some observations on intercellular contact membranes and intercellular space. Nature 201, 194-195.
28. Koppelhus U, Tranebjaerg L, Esberg G, Ramsing M, Lodahl M, Rendtorff ND, Olesen HV, Sommerlund M (2011). A novel mutation in the connexin 26 gene (GJB2) in a child with clinical and histological features of keratitis-ichthyosis- deafness (KID) syndrome. Clin Exp Dermatol 36, 142-148.
29. Labarthe MP, Bosco D, Saurat JH, Meda P, Salomon D (1998). Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J Invest Dermatol 111, 72-76. (Pubitemid 28309211)
30. Lawrence TS, Beers WH, Gilula NB (1978). Transmission of hormonal stimulation by cell-to-cell communication. Nature 272, 501-506. (Pubitemid 8312298)
31. Lazic T, Horii KA, Richard G, Wasserman DI, Antaya RJ (2008). A report of GJB2 (N14K) Connexin 26 mutation in two patients-a new subtype of KID syndrome? Pediatr Dermatol 25, 535-540.
32. Lee JR, Derosa AM, White TW (2009). Connexin mutations causing skin disease and deafness increase hemichannel activity and cell death when expressed in Xenopus oocytes. J Invest Dermatol 129, 870-878.
33. Lee JR, White TW (2009). Connexin-26 mutations in deafness and skin disease. Expert Rev Mol Med 11, e35.
34. Levit NA, Mese G, Basaly MG, White TW (2011). Pathological hemichannels associated with human Cx26 mutations causing keratitis-ichthyosis-deafness syndrome. Biochim Biophys Acta. doi:10.1016/j.bbamem.2011.09.003 [Epub ahead of print].
35. Lucke T, Choudhry R, Thom R, Selmer IS, Burden AD, Hodgins MB (1999). Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J Invest Dermatol 112, 354-361. (Pubitemid 29125113)
36. Maestrini E, Korge BP, Ocana-Sierra J, Calzolari E, Cambiaghi S, Scudder PM, Hovnanian A, Monaco AP, Munro CS (1999). A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 8, 1237-1243. (Pubitemid 29328992)
37. Maintz L, Betz RC, Allam JP, Wenzel J, Jaksche A, Friedrichs N, Bieber T, Novak N (2005). Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad. Eur J Dermatol 15, 347-352. (Pubitemid 41337411)
38. Masgrau-Peya E, Salomon D, Saurat JH, Meda P (1997). In vivo modulation of connexins 43 and 26 of human epidermis by topical retinoic acid treatment. J Histochem Cytochem 45, 1207-1215. (Pubitemid 27392328)
39. Mazereeuw-Hautier J et al. (2007). Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients. Br J Dermatol 156, 1015-1019. (Pubitemid 46642846)
40. Mese G, Londin E, Mui R, Brink PR, White TW (2004). Altered gating properties of functional Cx26 mutants associated with recessive non-syndromic hearing loss. Hum Genet 115, 191-199. (Pubitemid 39162199)
41. Mese G, Richard G, White TW (2007). Gap junctions: basic structure and function. J Invest Dermatol 127, 2516-2524. (Pubitemid 47585051)
42. Mese G, Valiunas V, Brink PR, White TW (2008). Connexin26 deafness associated mutations show altered permeability to large cationic molecules. Am J Physiol Cell Physiol 295, C966-C974.
43. Montgomery JR, White TW, Martin BL, Turner ML, Holland SM (2004). A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis- deafness syndrome and the follicular occlusion triad. J Am Acad Dermatol 51, 377-382. (Pubitemid 39178664)
44. Nguyen H, Rendl M, Fuchs E (2006). Tcf3 governs stem cell features and represses cell fate determination in skin. Cell 127, 171-183. (Pubitemid 44466637)
45. Nyquist GG et al. (2007). Malignant proliferating pilar tumors arising in KID syndrome: a report of two patients. Am J Med Genet A 143, 734-741. (Pubitemid 46606684)
46. Revel JP, Karnovsky MJ (1967). Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J Cell Biol 33, C7-C12.
47. Richard G (2000). Connexins: a connection with the skin. Exp Dermatol 9, 77-96.
48. Richard G (2001). Connexin disorders of the skin. Adv Dermatol 17, 243-277.
49. Richard G (2005). Connexin disorders of the skin. Clin Dermatol 23, 23-32.
50. Richard G, Brown N, Ishida-Yamamoto A, Krol A (2004). Expanding the phenotypic spectrum of Cx26 disorders: Bart-Pumphrey syndrome is caused by a novel missense mutation in GJB2. J Invest Dermatol 123, 856-863. (Pubitemid 39391929)
51. Richard G et al. (2002). Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet 70, 1341-1348. (Pubitemid 34450584)
52. Richard G, White TW, Smith LE, Bailey RA, Compton JG, Paul DL, Bale SJ (1998). Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet 103, 393-399. (Pubitemid 28542946)
53. Risek B, Klier FG, Gilula NB (1992). Multiple gap junction genes are utilized during rat skin and hair development. Development 116, 639-651.
54. Rivas MV, Jarvis ED, Morisaki S, Carbonaro H, Gottlieb AB, Krueger JG (1997). Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique. J Invest Dermatol 108, 188-194. (Pubitemid 27061030)
55. Robertson JD (1963). The occurrence of a subunit pattern in the unit membranes of club endings in Mauthner cell synapses in goldfish brains. J Cell Biol 19, 201-221.
56. Rouan F, White TW, Brown N, Taylor AM, Lucke TW, Paul DL, Munro CS, Uitto J, Hodgins MB, Richard G (2001). trans-Dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. J Cell Sci 114, 2105-2113. (Pubitemid 32586635)
57. Saez JC, Contreras JE, Bukauskas FF, Retamal MA, Bennett MV (2003). Gap junction hemichannels in astrocytes of the CNS. Acta Physiol Scand 179, 9-22. (Pubitemid 37083058)
58. Saez JC, Schalper KA, Retamal MA, Orellana JA, Shoji KF, Bennett MV (2010). Cell membrane permeabilization via connexin hemichannels in living and dying cells. Exp Cell Res 316, 2377-2389.
59. Salomon D, Masgrau E, Vischer S, Ullrich S, Dupont E, Sappino P, Saurat JH, Meda P (1994). Topography of mammalian connexins in human skin. J Invest Dermatol 103, 240-247. (Pubitemid 24234615)
60. Sanchez HA, Mese G, Srinivas M, White TW, Verselis VK (2010). Differentially altered Ca2+ regulation and Ca2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis ichthyosis deafness syndrome. J Gen Physiol 136, 47-62.
61. Sbidian E, Feldmann D, Bengoa J, Fraitag S, Abadie V, de Prost Y, Bodemer C, Hadj-Rabia S (2010). Germline mosaicism in keratitis-ichthyosis-deafness syndrome: pre-natal diagnosis in a familial lethal form. Clin Genet 77, 587-592.
62. Scemes E (2011). Nature of plasmalemmal functional "hemichannels. " Biochim Biophys Acta. doi:10.1016 [Epub ahead of print].
63. Scemes E, Spray DC, Meda P (2009). Connexins, pannexins, innexins: novel roles of "hemi-channels." Pflugers Arch 457, 1207-1226.
64. Schalper KA, Orellana JA, Berthoud VM, Saez JC (2009). Dysfunctions of the diffusional membrane pathways mediated by hemichannels in inherited and acquired human diseases. Curr Vasc Pharmacol 7, 486-505.
65. Schutz M, Auth T, Gehrt A, Bosen F, Korber I, Strenzke N, Moser T, Willecke K (2011). The connexin26 S17F mouse mutant represents a model for the human hereditary keratitis-ichthyosis-deafness syndrome. Hum Mol Genet 20, 28-39.
66. Stong BC, Chang Q, Ahmad S, Lin X (2006). A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels. Laryngoscope 116, 2205-2210. (Pubitemid 44912318)
67. Terrinoni A, Codispoti A, Serra V, Didona B, Bruno E, Nistico R, Giustizieri M, Alessandrini M, Campione E, Melino G (2010). Connexin 26 (GJB2) mutations, causing KID syndrome, are associated with cell death due to calcium gating deregulation. Biochem Biophys Res Commun 394, 909-914.
68. Tu CL, Oda Y, Komuves L, Bikle DD (2004). The role of the calcium-sensing receptor in epidermal differentiation. Cell Calcium 35, 265-273. (Pubitemid 38292370)
69. Valiunas V et al. (2005). Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol 568, 459-468. (Pubitemid 41555451)
70. van Steensel MA (2004). Gap junction diseases of the skin. Am J Med Genet C Semin Med Genet 131, 12-19.
71. van Steensel MA, Steijlen PM, Bladergroen RS, Hoefsloot EH, van Ravenswaaij-Arts CM, van Geel M (2004). A phenotype resembling the Clouston syndrome with deafness is associated with a novel missense GJB2 mutation. J Invest Dermatol 123, 291-293. (Pubitemid 38951822)
72. van Steensel MA, van Geel M, Nahuys M, Smitt JH, Steijlen PM (2002). A novel connexin 26 mutation in a patient diagnosed with keratitis-ichthyosis- deafness syndrome. J Invest Dermatol 118, 724-727. (Pubitemid 34309996)
73. Wei CJ, Xu X, Lo CW (2004). Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol 20, 811-838. (Pubitemid 39488659)
74. White TW (2000). Functional analysis of human Cx26 mutations associated with deafness. Brain Res Brain Res Rev 32, 181-183.
75. White TW, Paul DL (1999). Genetic diseases and gene knockouts reveal diverse connexin functions. Annu Rev Physiol 61, 283-310. (Pubitemid 29143172)